Method for treating anxiety
October 31, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesLipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions Piperidine compounds and their preparation and use Piperidine compounds and their preparation and use Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties Heterocyclic compounds and use Heterocyclic compounds and their use Patent #: 5328924 InventorsAssigneeApplicationNo. 332186 filed on 10/31/1994US Classes:514/305, Quinuclidines (including unsaturation)514/236.2, Three or more ring hetero atoms in the additional hetero ring514/340, Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.)514/342, Ring sulfur in the additional hetero ring514/362, 1,2,5-thiadiazoles (including hydrogenated)544/133, The five-membered hetero ring has at least sulfur and nitrogen as ring hetero atoms546/112, Bicyclo ring system having the six-membered hetero ring as one of the cyclos546/125, Additional hetero ring containing546/133, Quinuclidines (including unsaturated)546/137, Chalcogen bonded directly to ring carbon of the quinuclidine ring system546/177, Chalcogen attached directly to the carbocyclic ring of the quinoline ring system by nonionic bonding548/452Bicyclo ring system having the five-membered hetero ring as one of the cyclos (e.g., octahydroindoles, etc.)ExaminersPrimary: Killos, Paul J.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/44C07D 453/02 AbstractThe present invention provides a method for treating anxiety in humans using heterocyclic compounds.Other References
|
| ||||||||||||||
